Science Explorer Back to mapMap
Discussion
Researcher · Celon Pharma (Poland) · Poland

Monika Skupińska

Monika Skupińska publishes mostly in Molecular Biology, Pulmonary and Respiratory Medicine and Oncology, on topics such as Fibroblast Growth Factor Research, Lung Cancer Treatments and Mutations and Kruppel-like factors research.

OpenAlex
World rank
#5,513,584
of 7,710,434 ranked researchers
Rank in Poland
#50,009
of 100,960
Works
19
Citations
76
Citations per work
4.0
h-index
4
i10-index 3Top 98% in Molecular Biology
Monika Skupińska

What does Monika Skupińska research?

Monika Skupińska's work is mostly in Biochemistry, Genetics and Molecular Biology (54%), Medicine (30%), Immunology and Microbiology (4%).

Life Sciences: 11 works · 58.0% of their workBiochemistry, Genetics and Molecular Biology: 10 works · 54.0% of their workMolecular Biology: 9 works · 46.0% of their workCancer Research: 2 works · 8.0% of their workImmunology and Microbiology: 1 works · 4.0% of their workImmunology: 1 works · 4.0% of their workHealth Sciences: 6 works · 30.0% of their workMedicine: 6 works · 30.0% of their workPulmonary and Respiratory Medicine: 3 works · 18.0% of their workOncology: 2 works · 8.0% of their workRadiology, Nuclear Medicine and Imaging: 1 works · 4.0% of their workEverything else: 2 works · 12.0% of their workTHEIR WORKMonika Skupińska19works
Life Sciences58%Health Sciences30%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1054.0%
    2. Immunology and Microbiology14.0%
    1. Medicine630.0%
  3. Everything else212.0%
  1. 1Molecular Biology46% of their works
  2. 2Pulmonary and Respiratory Medicine18% of their works
  3. 3Oncology8% of their works
  4. 4Cancer Research8% of their works
  5. 5Immunology4% of their works
  6. 6Radiology, Nuclear Medicine and Imaging4% of their works

Research topics

Which keywords describe Monika Skupińska's research?

The keywords of their largest research topics: Cancer, FGF21, Fibroblast Growth Factor, Targeted Therapy, ALK Inhibitors, EGFR Mutations, Krüppel-like Factors and Transcriptional Regulation.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Cancer162 topics
  2. FGF21131 topic
  3. Fibroblast Growth Factor131 topic
  4. Targeted Therapy62 topics
  5. ALK Inhibitors41 topic
  6. EGFR Mutations41 topic
  7. Krüppel-like Factors31 topic
  8. Transcriptional Regulation31 topic
  9. CD4721 topic
  10. Cancer Genomics21 topic
  11. DNA Methylation21 topic
  12. HIF-121 topic
  13. Histone Modification21 topic
  14. Mutational Signatures21 topic
  15. RNA methylation21 topic
  16. Warburg Effect21 topic
  17. apoptotic cells21 topic
  18. m6A-seq21 topic

Where does Monika Skupińska work?

Monika Skupińska's main affiliation in the publication record is Celon Pharma (Poland), Poland.

How many publications and citations does Monika Skupińska have?

OpenAlex counts 19 works and 76 citations for Monika Skupińska, an h-index of 4, ranking #5,513,584 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Monika Skupińska. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.